Clinical Trial

Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 12, 2026 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-25; most recent amendment 2026-03-10.
Status change: Not Yet Recruiting → Recruiting 2025-09-18
Trial Details
NCT Number NCT06903676
Lead Sponsor Indiana University
Conditions Pancreatitis, Pancreatectomy
Enrollment 50 participants
Start Date 2025-08-05
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-12